HCV-GLUE is a sequence-oriented resource for comparative genomic analysis of hepatitis C virus (HCV), developed using the GLUE software framework. It includes a web interface that can be used to create an HCV-GLUE web-server.
Hepatitis C virus (HCV) is a bloodborne RNA virus that primarily targets the liver, causing both acute and chronic hepatitis. Classified under the Hepacivirus genus within the Flaviviridae family, HCV is mainly transmitted through contact with infected blood. If left untreated, infection can lead to serious liver complications, such as cirrhosis and liver cancer. Direct-acting antiviral medications have dramatically improved cure rates and hold the potential to eliminate the virus. However, achieving global elimination faces significant challenges
GLUE is an open, integrated software toolkit designed for storing and interpreting sequence data. It supports the creation of bespoke projects, incorporating essential data items for comparative genomic analysis, such as sequences, multiple sequence alignments, genome feature annotations, and other associated data.
Projects are loaded into the GLUE "engine," forming a relational database that represents the semantic relationships between data items. This foundation supports systematic comparative analyses and the development of sequence-based resources.
HCV-GLUE contains HCV feature definitions, annotated reference sequences for all HCV genotypes and subtypes, and heirarchically ordered multiple sequence alignments. It also contains functionality for assigning HCV sequences (including sub-genomic sequences) to subtypes and genotypes, using a maximium likelihood-based genotyping protocol.
Please see the User Guide for more details.
This HCV-GLUE project can be extended with additional layers, openly available via GitHub, including:
- NCBI-HCV-GLUE: extends HCV-GLUE through the incorporation of all HCV sequence data published in NCBI GenBank.
- PHE-HCV-DRUG-RESISTANCE: a drug resistance-focused extension incorporating an analysis tool that provides genotypic assessment of drug resistance/susceptibility.
- HCV-NABS: an extension for analysing neutralising antibody binding sites in HCV.
A web instance of HCV-GLUE incorporating both these extension layers is hosted by the University of Glasgow, and can be accessed here.
Please visit the HCV GLUE web page for instructions on installing HCV-GLUE.
GLUE contains an interactive command line environment focused on the development and use of GLUE projects by bioinformaticians. This provides a range of productivity-oriented features such as automatic command completion, command history and interactive paging through tabular data. Some examples are provided here.
For detailed instructions on how to use HCV-GLUE for your comparative genomic analysis, refer to the GLUE software environment's reference documentation.
We welcome contributions from the community! If you're interested in contributing to HCV-GLUE, please review our Contribution Guidelines.
The project is licensed under the GNU Affero General Public License v. 3.0
For questions, issues, or feedback, please contact us at [email protected] or open an issue on the GitHub repository.